215 related articles for article (PubMed ID: 2782327)
1. Effort blood pressure control in the course of antihypertensive treatment.
de Divitiis O; Di Somma S; Liguori V; Petitto M; Magnotta C; Ausiello M; Natale N; Brignoli M; Galderisi M
Am J Med; 1989 Sep; 87(3C):46S-56S. PubMed ID: 2782327
[TBL] [Abstract][Full Text] [Related]
2. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension.
Panfilov V; Morris AD; Donnelly R; Scemama M; Reid JL
Br J Clin Pharmacol; 1995 Dec; 40(6):563-9. PubMed ID: 8703663
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of rilmenidine and atenolol on tests of autonomic function and mental and dynamic exercise in patients with essential hypertension.
Panfilov V; Morris AD; Donnelly R; Reid JL
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S44-7. PubMed ID: 8642805
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive drugs and baroreflex sensitivity. Effects of rilmenidine.
Harron DW
Am J Med; 1989 Sep; 87(3C):57S-62S. PubMed ID: 2506754
[TBL] [Abstract][Full Text] [Related]
5. [Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol].
Dallocchio M; Gosse P; Fillastre JP; Grollier G; Morand P; Drici M; Corcoran C
Presse Med; 1991 Aug 31-Sep 7; 20(27):1265-71. PubMed ID: 1832761
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive study of cardiac structure and function after rilmenidine for essential hypertension.
N'guyen van Cao A; Levy B; Slama R
Am J Cardiol; 1988 Feb; 61(7):72D-75D. PubMed ID: 2894163
[TBL] [Abstract][Full Text] [Related]
7. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
[TBL] [Abstract][Full Text] [Related]
8. Reduced hemodynamic responses to physical and mental stress under low-dose rilmenidine in healthy subjects.
Teixeira de Castro RR; Tibiriçá E; de Oliveira MA; Moreira PB; Catelli MF; Rocha NN; Nóbrega AC
Cardiovasc Drugs Ther; 2006 Apr; 20(2):129-34. PubMed ID: 16761192
[TBL] [Abstract][Full Text] [Related]
9. [Rilmenidine sympatholytic activity preserves mental and orthostatic sympathetic response and epinephrine secretion].
Esler M; Lux A; Jennings G; Hastings J; Socratous F; Lambert G
Arch Mal Coeur Vaiss; 2004; 97(7-8):786-92. PubMed ID: 15506067
[TBL] [Abstract][Full Text] [Related]
10. Dose-effect relationship of rilmenidine after chronic administration.
Luccioni R; Lambert M; Ambrosi P; Scemama M
Eur J Clin Pharmacol; 1993; 45(2):157-60. PubMed ID: 8223838
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and acceptability of rilmenidine for mild to moderate systemic hypertension.
Ostermann G; Brisgand B; Schmitt J; Fillastre JP
Am J Cardiol; 1988 Feb; 61(7):76D-80D. PubMed ID: 2894164
[TBL] [Abstract][Full Text] [Related]
12. Double-blind controlled study of rilmenidine versus hydrochlorothiazide in mild hypertension: clinical and renal haemodynamic evaluation.
Licata G; Scaglione R; Guillet C; Capuana G; Parrinello G; Indovina A; Lipari R; Mazzola G; Merlino G
J Hum Hypertens; 1993 Apr; 7(2):153-7. PubMed ID: 8510088
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of rilmenidine in elderly patients--comparison with hydrochlorothiazide. The Belgian Multicentre Study Group.
Pelemans W; Verhaeghe J; Creytens G; Coupez G; Van Dessel A; Opsomer M; Corcoran C
Am J Cardiol; 1994 Dec; 74(13):51A-57A. PubMed ID: 7998586
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular variability after rilmenidine challenge: assessment of acute dosing effects by means of spectral analysis.
Girard A; Février B; Elghozi JL
Fundam Clin Pharmacol; 1995; 9(4):366-71. PubMed ID: 8566936
[TBL] [Abstract][Full Text] [Related]
15. [Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
Scemama M; Février B; Beucler I; Dairou F
Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):595-601. PubMed ID: 9033699
[TBL] [Abstract][Full Text] [Related]
16. Short-term effects of rilmenidine on left ventricular hypertrophy and systolic and diastolic function in patients with essential hypertension: comparison with an angiotensin converting enzyme inhibitor and a calcium antagonist.
Koldas L; Ayan F; Ikitimur B
Jpn Heart J; 2003 Sep; 44(5):693-704. PubMed ID: 14587651
[TBL] [Abstract][Full Text] [Related]
17. Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects.
de Visser SJ; van Gerven JM; Schoemaker RC; Cohen AF
Br J Clin Pharmacol; 2001 May; 51(5):423-8. PubMed ID: 11421999
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
Widimský J; Sirotiaková J
Curr Med Res Opin; 2006 Jul; 22(7):1287-94. PubMed ID: 16834827
[TBL] [Abstract][Full Text] [Related]
19. [Multicenter, double-blind study comparing rilmenidine 1 mg and hydrochlorothiazide 25 mg in 244 patients].
Fiorentini C; Guillet C; Guazzi M
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():39-46. PubMed ID: 2517008
[TBL] [Abstract][Full Text] [Related]
20. Rilmenidine--its antihypertensive efficacy, safety and impact on quality of life in perimenopausal women with mild to moderate essential hypertension.
Kawecka-Jaszcz K; Czarnecka D; Klocek M; Zabojszcz M; Kucharska M; Jaworski R; Pachocki R
Blood Press; 2006; 15(1):51-8. PubMed ID: 16492616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
